-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027

PUBT·09/30/2026 20:09:10
Listen to the news
Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027
  • Benitec Biopharma engaged Ernst & Young as its independent registered public accounting firm for the fiscal year ending June 30, 2027.
  • EY completed its client acceptance procedures on Sept. 28, 2026.
  • An engagement letter with EY was executed on Sept. 29, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Benitec Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-409052), on September 30, 2026, and is solely responsible for the information contained therein.